Several top pharmaceutical companies around the world have fast-tracked their efforts to come up with an effective vaccine against the novel coronavirus. US-based Moderna biotech is one of the front-runners in the race to launch a vaccine with the company's current vaccine candidate in final phases of clinical trials. In a latest development, Moderna has disclosed the price of the vaccine, which it plans to provide to some customers under 'pandemic pricing'.
Several top pharmaceutical companies around the world have fast-tracked their efforts to come up with an effective vaccine against the novel coronavirus. US-based Moderna biotech is one of the front-runners in the race to launch a vaccine with the company's current vaccine candidate in final phases of clinical trials. In a latest development, Moderna has disclosed the price of the vaccine, which it plans to provide to some customers under 'pandemic pricing'. August 06, 2020 at 08:05AM https://ift.tt/3kfAeWX
No comments:
Post a Comment